{"id":1993,"date":"2024-11-28T10:04:41","date_gmt":"2024-11-28T10:04:41","guid":{"rendered":"https:\/\/dnapartners.fr\/page-mica\/"},"modified":"2025-01-27T14:33:31","modified_gmt":"2025-01-27T14:33:31","slug":"mica-standards-and-guidelines-tracker","status":"publish","type":"page","link":"https:\/\/dnapartners.fr\/en\/mica-standards-and-guidelines-tracker\/","title":{"rendered":"MiCA Standards and Guidelines Tracker"},"content":{"rendered":"\n<table id=\"tablepress-1\" class=\"tablepress tablepress-id-1 tbody-has-connected-cells\">\n<thead>\n<tr class=\"row-1\">\n\t<th class=\"column-1\">Publication date<\/th><th class=\"column-2\">Theme<\/th><th class=\"column-3\">Supervisory Authority<\/th><th class=\"column-4\">Tag<\/th><th class=\"column-5\">Type<\/th><th class=\"column-6\">Consultation paper<\/th><th class=\"column-7\">Final Publication<\/th><th class=\"column-8\">Publication Number<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr class=\"row-2\">\n\t<td class=\"column-1\">09\/19\/2025<\/td><td class=\"column-2\">Position on the ESMA guidelines on supervisory practices enabling competent authorities to prevent and detect market abuse under MiCA<\/td><td class=\"column-3\">AMF<\/td><td class=\"column-4\">Others<\/td><td class=\"column-5\">AMF Position<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.amf-france.org\/sites\/institutionnel\/files\/private\/2025-09\/position-amf-2025-07-orientations-esma-mica-abus-de-marche_2.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">DOC-2025-07<\/td>\n<\/tr>\n<tr class=\"row-3\">\n\t<td class=\"column-1\">08\/20\/2025<\/td><td class=\"column-2\">RTS on arrangements, systems and procedures to prevent, detect and report market abuse, the templates for reporting suspected market abuse, and coordination procedures between competent authorities for detecting and addressing market abuse<br \/>\n<\/td><td class=\"column-3\">UE Commission<\/td><td class=\"column-4\">Others<\/td><td class=\"column-5\">R\u00e8glement D\u00e9l\u00e9gu\u00e9<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/eur-lex.europa.eu\/eli\/reg_del\/2025\/885\/oj\/eng\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">Commission Delegated Regulation (UE) 2025\/885<br \/>\n<\/td>\n<\/tr>\n<tr class=\"row-4\">\n\t<td rowspan=\"2\" class=\"column-1\">07\/11\/2025<\/td><td class=\"column-2\">Guidelines (Final Report) on the criteria for assessing knowledge and competence under MiCA<br \/>\n<\/td><td class=\"column-3\">ESMA<\/td><td class=\"column-4\">CASPs<br \/>\r\n<\/td><td class=\"column-5\">Guidelines &amp; Recommendations<\/td><td class=\"column-6\"><\/td><td class=\"column-7\"><a href=\"https:\/\/www.esma.europa.eu\/sites\/default\/files\/2025-07\/ESMA35-1872330276-2380_Final_Report_on_MiCA_Guidelines_on_knowledge_and_competence.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">ESMA35-1872330276-2380<\/td>\n<\/tr>\n<tr class=\"row-5\">\n\t<td class=\"column-2\">Guide for CASPs providing non regulated services<br \/>\n<\/td><td class=\"column-3\">ESMA<\/td><td class=\"column-4\">CASPs<br \/>\r\n<\/td><td class=\"column-5\">Guidelines &amp; Recommendations<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.esma.europa.eu\/sites\/default\/files\/2025-07\/ESMA35-1872330276-2329_-_MiCA_Statement_Access_to_Unregulated_Activities.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">ESMA35-1872330276-2329<\/td>\n<\/tr>\n<tr class=\"row-6\">\n\t<td class=\"column-1\">07\/09\/2025<\/td><td class=\"column-2\">Guidelines on supervisory practices enabling competent authorities to prevent and detect market abuse under MiCA<br \/>\n<\/td><td class=\"column-3\">ESMA<\/td><td class=\"column-4\">Others<\/td><td class=\"column-5\">Guidelines &amp; Recommendations<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.esma.europa.eu\/sites\/default\/files\/2025-07\/ESMA75-453128700-1039_Guidelines_on_supervisory_practices_to_prevent_and_detect_market_abuse__MiCA_.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">ESMA75-453128700-1039<\/td>\n<\/tr>\n<tr class=\"row-7\">\n\t<td class=\"column-1\">07\/02\/2025<\/td><td class=\"column-2\">Position on the joint EBA and ESMA guidelines on the assessment of the suitability of the members of the management body of asset-referenced token issuers and CASPs<br \/>\n<\/td><td class=\"column-3\">AMF<\/td><td class=\"column-4\">CASPs, Issuers<br \/>\r\n<\/td><td class=\"column-5\">AMF Position<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.amf-france.org\/sites\/institutionnel\/files\/private\/2025-07\/doc-2025-06-vf.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">DOC-2025-06<\/td>\n<\/tr>\n<tr class=\"row-8\">\n\t<td class=\"column-1\">06\/17\/2025<\/td><td class=\"column-2\">Instructions on the information deemed complete for assessing an application for CASP authorization<br \/>\n<\/td><td class=\"column-3\">AMF<\/td><td class=\"column-4\">CASPs<br \/>\r\n<\/td><td class=\"column-5\">Guidelines &amp; Recommendations<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.amf-france.org\/sites\/institutionnel\/files\/private\/2025-06\/instruction-doc-2025-05_va_3.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">DOC 2025-05<\/td>\n<\/tr>\n<tr class=\"row-9\">\n\t<td rowspan=\"2\" class=\"column-1\">06\/10\/2025<\/td><td class=\"column-2\">RTS specifying the requirements for policies and procedures on conflicts of interest for ART issuers<br \/>\n<\/td><td class=\"column-3\">UE Commission<\/td><td class=\"column-4\">Issuers<br \/>\r\n<\/td><td class=\"column-5\">Delegated Regulation<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/eur-lex.europa.eu\/eli\/reg_del\/2025\/1141\/oj\/eng\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">Commission Delegated Regulation (EU) 2025\/1141<\/td>\n<\/tr>\n<tr class=\"row-10\">\n\t<td class=\"column-2\">RTS on records to be kept for all crypto-asset services, activities, orders and transactions carried out<\/td><td class=\"column-3\">UE Commission<\/td><td class=\"column-4\">CASPs<br \/>\r\n<\/td><td class=\"column-5\">Delegated Regulation<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/?uri=OJ%3AL_202501140\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">Commission Delegated Regulation (EU) 2025\/1140<\/td>\n<\/tr>\n<tr class=\"row-11\">\n\t<td class=\"column-1\">03\/26\/2025<\/td><td class=\"column-2\">Guidelines on certain aspects of the suitability requirements and format of the periodic statement for portfolio management activities under MiCA<\/td><td class=\"column-3\">ESMA<\/td><td class=\"column-4\">CASPs<br \/>\n<\/td><td class=\"column-5\">Guidelines &amp; Recommendations<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.esma.europa.eu\/sites\/default\/files\/2025-03\/ESMA35-1872330276-2031_Guidelines_on_suitability_and_periodic_statement_MiCA.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">ESMA35-1872330276-2031<\/td>\n<\/tr>\n<tr class=\"row-12\">\n\t<td rowspan=\"4\" class=\"column-1\">03\/24\/2025<\/td><td class=\"column-2\">RTS for own funds requirements for issuers of significant ARTs and EMTs<\/td><td class=\"column-3\">UE Commission<\/td><td class=\"column-4\">Issuers<br \/>\n<\/td><td class=\"column-5\">Delegated Regulation<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/eur-lex.europa.eu\/legal-content\/en\/TXT\/?uri=CELEX:32025R0415\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">Commission Delegated Regulation (EU) 2025\/415 <\/td>\n<\/tr>\n<tr class=\"row-13\">\n\t<td class=\"column-2\">RTS on the minimum contents of the governance arrangements on the remuneration policy of issuers of significant ARTs and EMTS<\/td><td class=\"column-3\">UE Commission<\/td><td class=\"column-4\">Issuers<br \/>\r\n<\/td><td class=\"column-5\">Delegated Regulation<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/eur-lex.europa.eu\/legal-content\/en\/TXT\/?uri=CELEX:32025R0418\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">Commission Delegated Regulation (EU) 2025\/418<\/td>\n<\/tr>\n<tr class=\"row-14\">\n\t<td class=\"column-2\">RTS on the necessary data for the classification of crypto-asset white papers<\/td><td class=\"column-3\">UE Commission<\/td><td class=\"column-4\">CASPs, Issuers<br \/>\r\n<\/td><td class=\"column-5\">Delegated Regulation<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/eur-lex.europa.eu\/legal-content\/en\/TXT\/?uri=CELEX:32025R0421\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">Commission Delegated Regulation (EU) 2025\/421 <\/td>\n<\/tr>\n<tr class=\"row-15\">\n\t<td class=\"column-2\">RTS on the adjustment of own funds for issuers of significant ARTs and EMTs<\/td><td class=\"column-3\">UE Commission<\/td><td class=\"column-4\">Issuers<br \/>\r\n<\/td><td class=\"column-5\">Delegated Regulation<\/td><td class=\"column-6\"><\/td><td class=\"column-7\"><a href=\"https:\/\/eur-lex.europa.eu\/legal-content\/en\/TXT\/?uri=CELEX:32025R0419\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">Commission Delegated Regulation (EU) 2025\/419<\/td>\n<\/tr>\n<tr class=\"row-16\">\n\t<td class=\"column-1\">03\/19\/2025<\/td><td class=\"column-2\">Guidelines<br \/>\nOn the conditions and criteria for the qualification of crypto-assets as<br \/>\nfinancial instruments<\/td><td class=\"column-3\">ESMA<\/td><td class=\"column-4\">CASPs, Issuers<br \/>\r\n<\/td><td class=\"column-5\">Guidelines &amp; Recommendations<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.esma.europa.eu\/sites\/default\/files\/2025-03\/ESMA75453128700-1323_Guidelines_on_the_conditions_and_criteria_for_the_qualification_of_CAs_as_FIs.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">ESMA75453128700-1323<\/td>\n<\/tr>\n<tr class=\"row-17\">\n\t<td class=\"column-1\">03\/14\/2025<\/td><td class=\"column-2\">RTS on the content and format of order book records to be maintained<\/td><td class=\"column-3\">UE Commission<\/td><td class=\"column-4\">CASPs<\/td><td class=\"column-5\">Delegated Regulation <\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/eur-lex.europa.eu\/legal-content\/en\/TXT\/?uri=CELEX:32025R0416\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">Commission Delegated Regulation (EU) 2025\/416<\/td>\n<\/tr>\n<tr class=\"row-18\">\n\t<td class=\"column-1\">03\/14\/2025<\/td><td class=\"column-2\">RTS on the offering of post and pre-trade data to the public<\/td><td class=\"column-3\">UE Commission<\/td><td class=\"column-4\">CASPs<\/td><td class=\"column-5\">Delegated Regulation Act<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/eur-lex.europa.eu\/legal-content\/en\/TXT\/?uri=CELEX:32025R0417\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">Commission Delegated Regulation (EU) 2025\/417<\/td>\n<\/tr>\n<tr class=\"row-19\">\n\t<td class=\"column-1\">03\/10\/2025<\/td><td class=\"column-2\">Guidelines on explanations and opinions, and the standardised test for crypto-assets under MiCA<\/td><td class=\"column-3\">ESMA, EBA, EIOPA<\/td><td class=\"column-4\">CASPs, Issuers<br \/>\n<\/td><td class=\"column-5\">Guidelines &amp; Recommendation<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.esma.europa.eu\/sites\/default\/files\/2025-03\/JC_2024_28_Guidelines_on_explanations_and_opinions__and_the_standardised_test_for_crypto-assets_under_MiCA.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">JC 2024 28<\/td>\n<\/tr>\n<tr class=\"row-20\">\n\t<td class=\"column-1\">03\/04\/2025<\/td><td class=\"column-2\">EBA Public hearing \u2013<br \/>\r\nConsultation paper on Draft RTS on<br \/>\r\ncalculation and aggregation of<br \/>\r\ncrypto exposure values<\/td><td class=\"column-3\">EBA<\/td><td class=\"column-4\">CASPs, Issuers, Others<\/td><td class=\"column-5\">Public hearing<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.eba.europa.eu\/sites\/default\/files\/2025-03\/9a38ede1-7a3e-4eb0-b233-7b98800d7bbc\/Public%20hearing%20-%20CP%20on%20draft%20RTS%20crypto%20asset%20exposures.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">-<\/td>\n<\/tr>\n<tr class=\"row-21\">\n\t<td class=\"column-1\">02\/27\/2025<\/td><td class=\"column-2\">Opinion on European Commission's proposed amendment to RTS authorisation ARTs under MiCAR<\/td><td class=\"column-3\">EBA<\/td><td class=\"column-4\">Issuers<\/td><td class=\"column-5\">Opinion<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.eba.europa.eu\/sites\/default\/files\/2025-02\/900963a5-fcd2-45a6-b2da-1007afc2b234\/Opinion%20on%20EC%20proposed%20amendment%20to%20RTS%20authorisation%20ARTs.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">EBA\/Op\/2025\/03<\/td>\n<\/tr>\n<tr class=\"row-22\">\n\t<td rowspan=\"3\" class=\"column-1\">02\/26\/2025<\/td><td class=\"column-2\">Transfer services for crypto-assets <\/td><td class=\"column-3\">ESMA<\/td><td class=\"column-4\">CASPs, Others<\/td><td class=\"column-5\">Guidelines &amp; Recommendation<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.esma.europa.eu\/sites\/default\/files\/2025-02\/ESMA35-1872330276-2032_Guidelines_on_transfer_services_for_crypto-assets_under_MiCA.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">ESMA35-1872330276-2032<\/td>\n<\/tr>\n<tr class=\"row-23\">\n\t<td class=\"column-2\">Reverse solicitation<\/td><td class=\"column-3\">ESMA<\/td><td class=\"column-4\">CASPs, Issuers, Others<\/td><td class=\"column-5\">Guidelines &amp; Recommendation<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.esma.europa.eu\/sites\/default\/files\/2025-02\/ESMA35-1872330276-2030_Guidelines_on_reverse_solicitation_under_MiCA.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">ESMA35-1872330276-2030<\/td>\n<\/tr>\n<tr class=\"row-24\">\n\t<td class=\"column-2\">Maintenance of systems and security access protocols<\/td><td class=\"column-3\">ESMA<\/td><td class=\"column-4\">CASPs, Issuers, Others<\/td><td class=\"column-5\">Guidelines &amp; Recommendation<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.esma.europa.eu\/sites\/default\/files\/2025-02\/ESMA75-223375936-6132_Guidelines_on_maintenance_of_systems_and_security_access_protocols_under_MiCA.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">ESMA75-223375936-6132<\/td>\n<\/tr>\n<tr class=\"row-25\">\n\t<td rowspan=\"2\" class=\"column-1\">02\/20\/2025<\/td><td class=\"column-2\">ITS Forms and templates of notification of certain entities to competent authorities<\/td><td class=\"column-3\">UE Commission<\/td><td class=\"column-4\">CASPs<\/td><td class=\"column-5\">Implementing Regulation Act<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/eur-lex.europa.eu\/legal-content\/en\/TXT\/?uri=CELEX:32025R0304\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">Commission Implementing Regulation (EU) 2025\/304<\/td>\n<\/tr>\n<tr class=\"row-26\">\n\t<td class=\"column-2\">RTS Notification of selected entities to competent authorities<\/td><td class=\"column-3\">UE Commission<\/td><td class=\"column-4\">CASPs<\/td><td class=\"column-5\">Delegated Regulation Act<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/eur-lex.europa.eu\/legal-content\/en\/TXT\/?uri=CELEX:32025R0303\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">Commission Delegated Regulation (EU) 2025\/303<\/td>\n<\/tr>\n<tr class=\"row-27\">\n\t<td class=\"column-1\">02\/17\/2025<\/td><td class=\"column-2\">Guidelines for the criteria on the assessment of knowledge and<br \/>\ncompetence under MiCA<br \/>\n<\/td><td class=\"column-3\">ESMA<\/td><td class=\"column-4\">CASPs, Issuers<br \/>\r\n<\/td><td class=\"column-5\">Draft Guidelines <\/td><td class=\"column-6\"><a href=\"https:\/\/www.esma.europa.eu\/sites\/default\/files\/2025-02\/ESMA35-1872330276-2004_MiCA_-_Consultation_Paper_-_Guidelines_on_knowledge_and_competence.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-7\">-<\/td><td class=\"column-8\">ESMA35-1872330276-2004<\/td>\n<\/tr>\n<tr class=\"row-28\">\n\t<td rowspan=\"7\" class=\"column-1\">02\/13\/2025<\/td><td class=\"column-2\">RTS on measures ensuring continuity and regulatory in performance of CASPs<\/td><td class=\"column-3\">UE Commission<\/td><td class=\"column-4\">CASPs<\/td><td class=\"column-5\">Delegated Regulation Act <\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/eur-lex.europa.eu\/legal-content\/en\/TXT\/?uri=CELEX:32025R0299\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">Commission Delegated Regulation (EU) 2025\/299<\/td>\n<\/tr>\n<tr class=\"row-29\">\n\t<td class=\"column-2\">RTS on the use of asset-referenced tokens as a means of exchange within a single currency area<\/td><td class=\"column-3\">UE Commission<\/td><td class=\"column-4\">Issuers, Others<\/td><td class=\"column-5\">Delegated Regulation Act<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/eur-lex.europa.eu\/legal-content\/en\/TXT\/?uri=CELEX:32025R0298\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">Commission Delegated Regulation (EU) 2025\/298<\/td>\n<\/tr>\n<tr class=\"row-30\">\n\t<td class=\"column-2\">RTS on the approval of the crypto-asset white paper issued by credit institutions<\/td><td class=\"column-3\">UE Commission<\/td><td class=\"column-4\">CASPs, Issuers, Others<\/td><td class=\"column-5\">Delegated Regulation Act<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/eur-lex.europa.eu\/legal-content\/en\/TXT\/?uri=CELEX:32025R0296\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">Commission Delegated Regulation (EU) 2025\/296<\/td>\n<\/tr>\n<tr class=\"row-31\">\n\t<td class=\"column-2\">RTS on the handling of complaints by issuers of ARTs<\/td><td class=\"column-3\">UE Commission<\/td><td class=\"column-4\">CASPs, Issuers<br \/>\r\n<\/td><td class=\"column-5\">Delegated Regulation Act<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/eur-lex.europa.eu\/legal-content\/en\/TXT\/?uri=CELEX:32025R0293\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">Commission Delegated Regulation (EU) 2025\/293<\/td>\n<\/tr>\n<tr class=\"row-32\">\n\t<td class=\"column-2\">RTS Template for cooperation arrangements with third countries<\/td><td class=\"column-3\">UE Commission<\/td><td class=\"column-4\">Others<\/td><td class=\"column-5\">Delegated Regulation Act<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/eur-lex.europa.eu\/legal-content\/en\/TXT\/?uri=CELEX:32025R0292\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">Commission Delegated Regulation (EU) 2025\/292<\/td>\n<\/tr>\n<tr class=\"row-33\">\n\t<td class=\"column-2\">RTS Complaint handling procedure for CASPs<\/td><td class=\"column-3\">UE Commission<\/td><td class=\"column-4\">CASPs, Issuers<br \/>\r\n<\/td><td class=\"column-5\">Delegated Regulation Act<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/eur-lex.europa.eu\/legal-content\/en\/TXT\/?uri=CELEX:32025R0294\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">Commission Delegated Regulation (EU) 2025\/294<\/td>\n<\/tr>\n<tr class=\"row-34\">\n\t<td class=\"column-2\">RTS on supervisory colleges<\/td><td class=\"column-3\">UE Commission<\/td><td class=\"column-4\">Issuers, Others<\/td><td class=\"column-5\">Delegated Regulation Act<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/eur-lex.europa.eu\/eli\/reg_del\/2025\/297\/oj\/eng\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">Commission Delegated Regulation (EU) 2025\/297<\/td>\n<\/tr>\n<tr class=\"row-35\">\n\t<td class=\"column-1\">02\/05\/2025<\/td><td class=\"column-2\">Opinion on conflicts of interests for<br \/>\nissuers of ARTs (Article<br \/>\n32)<br \/>\n<\/td><td class=\"column-3\">EBA<\/td><td class=\"column-4\">CASPs<\/td><td class=\"column-5\">Opinion<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.eba.europa.eu\/sites\/default\/files\/2025-02\/c5e32ba1-0bdf-4772-8d91-176f0b60dabf\/Opinion%20on%20EC%20%20changes%20on%20%20RTS%20on%20conflicts%20of%20interest%20for%20issuers.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">EBA\/Op\/2025\/02<\/td>\n<\/tr>\n<tr class=\"row-36\">\n\t<td class=\"column-1\">02\/03\/2025<\/td><td class=\"column-2\">Approval of amendments to the General Regulation of the French Financial Markets Authority<\/td><td class=\"column-3\">AMF<\/td><td class=\"column-4\">CASPs, Issuers<br \/>\n<\/td><td class=\"column-5\">French Order<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.legifrance.gouv.fr\/jorf\/id\/JORFTEXT000051145834\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">-<\/td>\n<\/tr>\n<tr class=\"row-37\">\n\t<td class=\"column-1\">01\/31\/2025<\/td><td class=\"column-2\">Authorisation of CASPs under MiCA<\/td><td class=\"column-3\">ESMA<\/td><td class=\"column-4\">CASPs<\/td><td class=\"column-5\">Briefing<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.esma.europa.eu\/sites\/default\/files\/2025-01\/ESMA75-453128700-1263_Supervisory_Briefing_on_Authorisation_of_CASPs.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">ESMA75-453128700-1263<\/td>\n<\/tr>\n<tr class=\"row-38\">\n\t<td rowspan=\"3\" class=\"column-1\">01\/24\/2025<\/td><td class=\"column-2\">Factsheet on recent developments in crypto-assets : DeFi<\/td><td class=\"column-3\">EBA, ESMA<\/td><td class=\"column-4\">CASPs, Issuers, Others <\/td><td class=\"column-5\">Factsheet <\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.esma.europa.eu\/sites\/default\/files\/2025-01\/EBA-ESMA_DeFi_factsheet.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">-<\/td>\n<\/tr>\n<tr class=\"row-39\">\n\t<td class=\"column-2\">Factsheet on recent development in crypto-assets : crypto lending and staking<\/td><td class=\"column-3\">EBA, ESMA<\/td><td class=\"column-4\">CASPs, Issuers, Others<\/td><td class=\"column-5\">Factsheet <\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.esma.europa.eu\/sites\/default\/files\/2025-01\/EBA-ESMA_crypto_lending_and_staking.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">-<\/td>\n<\/tr>\n<tr class=\"row-40\">\n\t<td class=\"column-2\">Opinion on RTS specifying certain requirement in relation to conflicts of interest for CASPs<\/td><td class=\"column-3\">ESMA<\/td><td class=\"column-4\">CASPs<\/td><td class=\"column-5\">Opinion<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.esma.europa.eu\/sites\/default\/files\/2025-01\/ESMA35-1872330276-2021_Opinion_on_amendments_to_RTS_on_CoIs_of_CASPs_under_MiCA.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">ESMA35-1872330276-2021<\/td>\n<\/tr>\n<tr class=\"row-41\">\n\t<td rowspan=\"2\" class=\"column-1\">01\/17\/2025<\/td><td class=\"column-2\">Q&amp;A Scope of public offering (stablecoin)<\/td><td class=\"column-3\">ESMA<\/td><td class=\"column-4\">Issuers, CASPs<\/td><td class=\"column-5\">Q&amp;As<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.esma.europa.eu\/publications-data\/questions-answers\/2404\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">ESMA_QA_2404<\/td>\n<\/tr>\n<tr class=\"row-42\">\n\t<td class=\"column-2\">Statement on the provision of certain crypto-asset services in relation to non-MiCA compliant ARTs and EMTs<\/td><td class=\"column-3\">ESMA<\/td><td class=\"column-4\">CASPs<\/td><td class=\"column-5\">Statement<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.esma.europa.eu\/sites\/default\/files\/2025-01\/ESMA75-223375936-6099_Statement_on_stablecoins.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">ESMA75-223375936-6099<\/td>\n<\/tr>\n<tr class=\"row-43\">\n\t<td class=\"column-1\"><br \/>\n01\/16\/2025<\/td><td class=\"column-2\">Joint EBA-ESMA Report on the recent development in crypto-assets (Art 142 of MiCA)<\/td><td class=\"column-3\">EBA, ESMA<\/td><td class=\"column-4\">Others<\/td><td class=\"column-5\">Joint Report<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.esma.europa.eu\/sites\/default\/files\/2025-01\/ESMA75-453128700-1391_Joint_Report_on_recent_developments_in_crypto-assets__Art_142_MiCA_.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">ESMA75-453128700-1391 EBA\/Rep\/2025\/01<\/td>\n<\/tr>\n<tr class=\"row-44\">\n\t<td class=\"column-1\">01\/14\/2025<\/td><td class=\"column-2\">SMSG advice on the role and competence of National Competent Authorities in supervising the crypto markets<\/td><td class=\"column-3\">ESMA (SMSG)<\/td><td class=\"column-4\">Others<\/td><td class=\"column-5\">Advice<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.esma.europa.eu\/sites\/default\/files\/2025-01\/ESMA24-229244789-5235_SMSG_Advice_on_NCA_Guidelines_to_detect_and_prevent_market_abuse_under_MiCA.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">ESMA24-229244789-5235<\/td>\n<\/tr>\n<tr class=\"row-45\">\n\t<td class=\"column-1\">12\/19\/2024<\/td><td class=\"column-2\">Statement on MiCA transitional measures<\/td><td class=\"column-3\">ESMA<\/td><td class=\"column-4\">CASPs<\/td><td class=\"column-5\">Statement<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.esma.europa.eu\/sites\/default\/files\/2024-12\/ESMA75-453128700-1396_Statement_on_MiCA_transitional_measures.pdf\" target=\"_blank\"><\/a><\/td><td class=\"column-8\">ESMA75-453128700-1396<\/td>\n<\/tr>\n<tr class=\"row-46\">\n\t<td rowspan=\"8\" class=\"column-1\">12\/18\/2024<\/td><td class=\"column-2\">Explainer \u2013 MiCAR templates<\/td><td class=\"column-3\">EBA<\/td><td class=\"column-4\">Issuers<\/td><td class=\"column-5\">Visual explainer<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.eba.europa.eu\/sites\/default\/files\/2024-12\/8142048c-a467-4b8c-9a04-9ea64fbfd40d\/Explainer%20-%20MiCAR%20templates.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">-<\/td>\n<\/tr>\n<tr class=\"row-47\">\n\t<td class=\"column-2\">Annex I \u2013 Reporting for issuers of ARTs and EMTs - templates<\/td><td class=\"column-3\">EBA<\/td><td class=\"column-4\">Issuers<\/td><td class=\"column-5\">Annex ITS<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.eba.europa.eu\/sites\/default\/files\/2024-12\/71f7ee53-2644-4539-a3cc-8fec5226bf7f\/Annex I - Reporting for issuers of ARTs and EMTs - templates.xlsx\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">-<\/td>\n<\/tr>\n<tr class=\"row-48\">\n\t<td class=\"column-2\">Annex II \u2013 Reporting for issuers of ARTs and EMTS - Instructions<\/td><td class=\"column-3\">EBA<\/td><td class=\"column-4\">Issuers<\/td><td class=\"column-5\">Annex ITS<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.eba.europa.eu\/sites\/default\/files\/2024-12\/e6ab5d12-9be4-4e89-807b-c405c63f93c7\/annex_ii_-_reporting_for_issuers_of_arts_and_emts_-_instructions.docx\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">-<\/td>\n<\/tr>\n<tr class=\"row-49\">\n\t<td class=\"column-2\">Annex III \u2013 Reporting for crypto-asset service providers - templates<\/td><td class=\"column-3\">EBA<\/td><td class=\"column-4\">CASPs<\/td><td class=\"column-5\">Annex ITS<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.eba.europa.eu\/sites\/default\/files\/2024-12\/b67d22c1-c9d4-4d70-a392-f7fc279455b9\/annex_iii_-_reporting_for_crypto-asset_service_providers_-_templates.xlsx\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">-<\/td>\n<\/tr>\n<tr class=\"row-50\">\n\t<td class=\"column-2\">Annex IV \u2013 Reporting for crypto-asset service providers - instructions<\/td><td class=\"column-3\">EBA<\/td><td class=\"column-4\">CASPs<\/td><td class=\"column-5\">Annex ITS<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.eba.europa.eu\/sites\/default\/files\/2024-12\/b3cc6f4c-0fc8-49f9-ac3a-0d5cf93b6d64\/annex_iv_-_reporting_for_crypto-asset_service_providers_-_instructions.docx\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">-<\/td>\n<\/tr>\n<tr class=\"row-51\">\n\t<td class=\"column-2\">Annex V \u2013 DPM and validation rules<\/td><td class=\"column-3\">EBA<\/td><td class=\"column-4\">CASPs<\/td><td class=\"column-5\">Annex ITS<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.eba.europa.eu\/sites\/default\/files\/2024-12\/2b03fc30-b121-41b1-89a6-c73750e94c08\/annex_v_-_dpm_and_validation_rules.docx\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">-<\/td>\n<\/tr>\n<tr class=\"row-52\">\n\t<td class=\"column-2\">Guidelines specifying certain requirements on investor protection<\/td><td class=\"column-3\">ESMA<\/td><td class=\"column-4\">CASPs<\/td><td class=\"column-5\">Guideline<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.esma.europa.eu\/sites\/default\/files\/2024-12\/ESMA35-1872330276-1936_MiCA_Final_Report_to_CP3_-_investor_protection_mandates.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">ESMA35-1872330276-1936<\/td>\n<\/tr>\n<tr class=\"row-53\">\n\t<td class=\"column-2\">Annex IV \u2013 reporting for issuers of ARTs and EMTs - templates<\/td><td class=\"column-3\">EBA<\/td><td class=\"column-4\">Issuers<\/td><td class=\"column-5\">Annex ITS<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"http:\/\/C:\\Users\\elisevaucelle\\Desktop\\d&amp;a partners\\MAJ MiCA tracker\\Sources\\EBA\\10.22.2024 Annex 4 reporting for issuers of ARTs and EMTs - templates.xlsx\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">-<\/td>\n<\/tr>\n<tr class=\"row-54\">\n\t<td rowspan=\"6\" class=\"column-1\">12\/18\/2024<\/td><td class=\"column-2\">Templates to report certain data points to the competent authorities<\/td><td class=\"column-3\">EBA<\/td><td class=\"column-4\">Issuers<\/td><td class=\"column-5\">Guideline<\/td><td class=\"column-6\"><a href=\"https:\/\/www.eba.europa.eu\/sites\/default\/files\/2024-07\/d3dfa861-0c63-43fd-871c-70a58eebac9c\/Consultation%20Paper%20on%20draft%20Guidelines%20on%20reporting%20on%20ARTs%20and%20EMTs.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-7\"><a href=\"https:\/\/www.eba.europa.eu\/sites\/default\/files\/2024-12\/907cde4b-7d25-4f41-b1ef-bb0a469f00ac\/Final%20report%20on%20Guidelines%20on%20reporting%20on%20ARTs%20and%20EMTs.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">EBA\/GL\/2024\/16 <\/td>\n<\/tr>\n<tr class=\"row-55\">\n\t<td class=\"column-2\">Annex I - Reporting for issuers of ARTs and EMTs templates<\/td><td class=\"column-3\">EBA<\/td><td class=\"column-4\">Issuers<\/td><td class=\"column-5\">Annex ITS<\/td><td class=\"column-6\"><a href=\"https:\/\/www.eba.europa.eu\/sites\/default\/files\/2024-07\/d3dfa861-0c63-43fd-871c-70a58eebac9c\/Consultation%20Paper%20on%20draft%20Guidelines%20on%20reporting%20on%20ARTs%20and%20EMTs.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-7\"><a href=\"https:\/\/www.eba.europa.eu\/sites\/default\/files\/2024-12\/907cde4b-7d25-4f41-b1ef-bb0a469f00ac\/Final%20report%20on%20Guidelines%20on%20reporting%20on%20ARTs%20and%20EMTs.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">-<\/td>\n<\/tr>\n<tr class=\"row-56\">\n\t<td class=\"column-2\">Annex II - Reporting for issuers of ARTs and EMTs - instructions<\/td><td class=\"column-3\">EBA<\/td><td class=\"column-4\">Issuers<\/td><td class=\"column-5\">Annex ITS<\/td><td class=\"column-6\"><a href=\"https:\/\/www.eba.europa.eu\/sites\/default\/files\/2024-07\/d3dfa861-0c63-43fd-871c-70a58eebac9c\/Consultation%20Paper%20on%20draft%20Guidelines%20on%20reporting%20on%20ARTs%20and%20EMTs.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-7\"><a href=\"https:\/\/www.eba.europa.eu\/sites\/default\/files\/2024-12\/907cde4b-7d25-4f41-b1ef-bb0a469f00ac\/Final%20report%20on%20Guidelines%20on%20reporting%20on%20ARTs%20and%20EMTs.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">-<\/td>\n<\/tr>\n<tr class=\"row-57\">\n\t<td class=\"column-2\">Annex III - Reporting for CASPs templates<\/td><td class=\"column-3\">EBA<\/td><td class=\"column-4\">CASPs<\/td><td class=\"column-5\">Annex ITS<\/td><td class=\"column-6\"><a href=\"https:\/\/www.eba.europa.eu\/sites\/default\/files\/2024-07\/d3dfa861-0c63-43fd-871c-70a58eebac9c\/Consultation%20Paper%20on%20draft%20Guidelines%20on%20reporting%20on%20ARTs%20and%20EMTs.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-7\"><a href=\"https:\/\/www.eba.europa.eu\/sites\/default\/files\/2024-12\/907cde4b-7d25-4f41-b1ef-bb0a469f00ac\/Final%20report%20on%20Guidelines%20on%20reporting%20on%20ARTs%20and%20EMTs.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">-<\/td>\n<\/tr>\n<tr class=\"row-58\">\n\t<td class=\"column-2\">Annex IV - Reporting for CASPs - instructions<\/td><td class=\"column-3\">EBA<\/td><td class=\"column-4\">Issuers<\/td><td class=\"column-5\">Annex ITS<\/td><td class=\"column-6\"><a href=\"https:\/\/www.eba.europa.eu\/sites\/default\/files\/2024-07\/d3dfa861-0c63-43fd-871c-70a58eebac9c\/Consultation%20Paper%20on%20draft%20Guidelines%20on%20reporting%20on%20ARTs%20and%20EMTs.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-7\"><a href=\"https:\/\/www.eba.europa.eu\/sites\/default\/files\/2024-12\/b3cc6f4c-0fc8-49f9-ac3a-0d5cf93b6d64\/annex_iv_-_reporting_for_crypto-asset_service_providers_-_instructions.docx\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">-<\/td>\n<\/tr>\n<tr class=\"row-59\">\n\t<td class=\"column-2\">Annex V \u2013 Data Point Model and validation rule<\/td><td class=\"column-3\">EBA<\/td><td class=\"column-4\">Issuers<\/td><td class=\"column-5\">Annex ITS<\/td><td class=\"column-6\"><a href=\"https:\/\/www.eba.europa.eu\/publications-and-media\/press-releases\/eba-consults-guidelines-reporting-data-assist-authorities-their-supervisory-duties-and-significance\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-7\"><a href=\"https:\/\/www.eba.europa.eu\/sites\/default\/files\/2024-12\/2b03fc30-b121-41b1-89a6-c73750e94c08\/annex_v_-_dpm_and_validation_rules.docx\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">-<\/td>\n<\/tr>\n<tr class=\"row-60\">\n\t<td class=\"column-1\">12\/17\/2024<\/td><td class=\"column-2\">Reverse solicitation<\/td><td class=\"column-3\">ESMA<\/td><td class=\"column-4\">CASPs, Issuers, Others (Reverse solicitation and broker model)<\/td><td class=\"column-5\">Guideline<\/td><td class=\"column-6\"><a href=\"https:\/\/www.esma.europa.eu\/sites\/default\/files\/2024-01\/ESMA35-1872330276-1619_Consultation_Paper_on_the_draft_guidelines_on_reverse_solicitation_under_MiCA.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-7\"><a href=\"https:\/\/www.esma.europa.eu\/sites\/default\/files\/2024-12\/ESMA35-1872330276-1899_-_Final_report_on_GLs_on_reverse_solicitation_under_MiCA.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">ESMA35-1872330276-1899<\/td>\n<\/tr>\n<tr class=\"row-61\">\n\t<td rowspan=\"3\" class=\"column-1\">12\/17\/2024<\/td><td class=\"column-2\">Maintenance of systems and security access protocols<\/td><td class=\"column-3\">ESMA<\/td><td class=\"column-4\">Issuers<\/td><td class=\"column-5\">Guideline<\/td><td class=\"column-6\"><a href=\"https:\/\/www.esma.europa.eu\/sites\/default\/files\/2024-03\/ESMA75-453128700-1002_MiCA_Consultation_Paper_-_RTS_market_abuse_and_GLs_on_investor_protection_and_operational_resilience.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-7\"><a href=\"https:\/\/www.esma.europa.eu\/sites\/default\/files\/2024-12\/ESMA75-223375936-6089_Final_Report_-_GLs_on_security_access_protocols_-_Art._14_1__d_.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">ESMA75-223375936-6089<\/td>\n<\/tr>\n<tr class=\"row-62\">\n\t<td class=\"column-2\">Arrangements, systems and procedures for detecting and reporting suspected market abuse in crypto-assets<\/td><td class=\"column-3\">ESMA<\/td><td class=\"column-4\">CASPs, Issuers, Others (Market abuse)<\/td><td class=\"column-5\">RTS<\/td><td class=\"column-6\"><a href=\"https:\/\/www.esma.europa.eu\/sites\/default\/files\/2024-03\/ESMA75-453128700-1002_MiCA_Consultation_Paper_-_RTS_market_abuse_and_GLs_on_investor_protection_and_operational_resilience.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-7\"><a href=\"https:\/\/www.esma.europa.eu\/sites\/default\/files\/2024-12\/ESMA75-453128700-1278_Final_Report_STOR_MiCA_Article_92_2_.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">ESMA75-453128700-1278<\/td>\n<\/tr>\n<tr class=\"row-63\">\n\t<td class=\"column-2\">Transfer services for crypto-assets : procedures, policies and clients\u2019 rights<\/td><td class=\"column-3\">ESMA<\/td><td class=\"column-4\">CASPs<\/td><td class=\"column-5\">Guideline<\/td><td class=\"column-6\"><a href=\"https:\/\/www.esma.europa.eu\/sites\/default\/files\/2024-03\/ESMA75-453128700-1002_MiCA_Consultation_Paper_-_RTS_market_abuse_and_GLs_on_investor_protection_and_operational_resilience.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-7\"><a href=\"https:\/\/www.esma.europa.eu\/sites\/default\/files\/2024-12\/ESMA35-1872330276-1936_MiCA_Final_Report_to_CP3_-_investor_protection_mandates.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">ESMA35-1872330276-1936<\/td>\n<\/tr>\n<tr class=\"row-64\">\n\t<td class=\"column-1\">12\/17\/2024<\/td><td class=\"column-2\">Criteria on the qualification of crypto assets as financial instruments<\/td><td class=\"column-3\">ESMA<\/td><td class=\"column-4\">Issuers, CASPs, Others (Classification of crypto-assets)<\/td><td class=\"column-5\">Guideline<\/td><td class=\"column-6\"><a href=\"https:\/\/www.esma.europa.eu\/sites\/default\/files\/2024-01\/ESMA75-453128700-52_MiCA_Consultation_Paper_-_Guidelines_on_the_qualification_of_crypto-assets_as_financial_instruments.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-7\"><a href=\"https:\/\/www.esma.europa.eu\/sites\/default\/files\/2024-12\/ESMA75453128700-1323_Final_Report_Guidelines_on_the_conditions_and_criteria_for_the_qualification_of_CAs_as_FIs.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">ESMA75-453128700-1323<\/td>\n<\/tr>\n<tr class=\"row-65\">\n\t<td class=\"column-1\">12\/17\/2024<\/td><td class=\"column-2\">Aspects of the suitability requirements and format of the periodic statement for portfolio management<\/td><td class=\"column-3\">ESMA<\/td><td class=\"column-4\">CASPs<\/td><td class=\"column-5\">Guideline<\/td><td class=\"column-6\"><a href=\"https:\/\/www.esma.europa.eu\/sites\/default\/files\/2024-03\/ESMA75-453128700-1002_MiCA_Consultation_Paper_-_RTS_market_abuse_and_GLs_on_investor_protection_and_operational_resilience.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-7\"><a href=\"https:\/\/www.esma.europa.eu\/sites\/default\/files\/2024-12\/ESMA35-1872330276-1936_MiCA_Final_Report_to_CP3_-_investor_protection_mandates.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">ESMA35-1872330276-1936<\/td>\n<\/tr>\n<tr class=\"row-66\">\n\t<td rowspan=\"2\" class=\"column-1\">12\/10\/2024<\/td><td class=\"column-2\">Guidelines on templates for explanations and crypto-asset classification test<\/td><td class=\"column-3\">EBA, ESMA, EIOPA<\/td><td class=\"column-4\">Issuers<\/td><td class=\"column-5\">Guideline<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.eba.europa.eu\/sites\/default\/files\/2024-12\/f4d876e5-5351-4314-b45f-ac3cd702f95b\/Joint%20ESA%20Final%20Report%20on%20Art%2097%20Guidelines%20MiCAR.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">ESA-2024-28<\/td>\n<\/tr>\n<tr class=\"row-67\">\n\t<td class=\"column-2\">Draft Guidelines on standardised test for the classification of crypto-assets<\/td><td class=\"column-3\">EBA, ESMA, EIOPA<\/td><td class=\"column-4\">Issuers, CASPs<\/td><td class=\"column-5\">Guideline<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.eba.europa.eu\/sites\/default\/files\/2024-07\/1de342e1-71c0-4b61-bb98-420e8251bfea\/Consultation%20paper%20on%20draft%20ESAs%20Guidelines%20on%20Art%2097%20MiCAR.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">ESA-2024-28<\/td>\n<\/tr>\n<tr class=\"row-68\">\n\t<td class=\"column-1\">10\/11\/2024<\/td><td class=\"column-2\">Opinion on RTS  for regulated financial institutions intending to offer crypto-asset services<\/td><td class=\"column-3\">ESMA<\/td><td class=\"column-4\">Issuers<\/td><td class=\"column-5\">Opinion<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.esma.europa.eu\/sites\/default\/files\/2024-10\/ESMA35-1872330276-195_-_MiCA_Opinion_on_rejection_of_RTS_CASPs_authorisations_and_notifications.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">ESMA35-1872330276-195<\/td>\n<\/tr>\n<tr class=\"row-69\">\n\t<td class=\"column-1\">10\/09\/2024<\/td><td class=\"column-2\">Redemption plans to be developed by issuers of ARTs and EMTs.<\/td><td class=\"column-3\">EBA<\/td><td class=\"column-4\">Issuers<\/td><td class=\"column-5\">Guideline<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.eba.europa.eu\/sites\/default\/files\/2024-10\/f8fda168-4d97-4549-9cfe-46d1d1a27636\/Final%20report%20on%20Guidelines%20on%20redemption%20plans%20under%20MiCAR.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">EBA\/GL\/2024\/13<\/td>\n<\/tr>\n<tr class=\"row-70\">\n\t<td class=\"column-1\">09\/17\/2024<\/td><td class=\"column-2\">Procedure for the classification of ARTs and EMTs as significant and  supervisory coordination of ARTs and EMTs<\/td><td class=\"column-3\">EBA<\/td><td class=\"column-4\">Issuers<\/td><td class=\"column-5\">Decision<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.eba.europa.eu\/sites\/default\/files\/2024-10\/6151cec3-ebd2-4e8e-a0e0-3ea9f8bd5c99\/EBA%20DC%20558_Decision%20on%20procedure%20for%20significance%20assessment%20MiCAR.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">EBA\/DC\/558<\/td>\n<\/tr>\n<tr class=\"row-71\">\n\t<td class=\"column-1\">07\/31\/2024<\/td><td class=\"column-2\">Opinion on broker models to ensure fair MiCA application<\/td><td class=\"column-3\">ESMA<\/td><td class=\"column-4\">CASPs<\/td><td class=\"column-5\">Opinion<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.esma.europa.eu\/sites\/default\/files\/2024-07\/ESMA75-453128700-1048_Opinion_on_broker_models.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">ESMA 75-453128700-1048<\/td>\n<\/tr>\n<tr class=\"row-72\">\n\t<td class=\"column-1\">07\/12\/2024<\/td><td class=\"column-2\">Q&amp;As on MiCA<\/td><td class=\"column-3\">ESMA<\/td><td class=\"column-4\">CASPs, Others<\/td><td class=\"column-5\">Q&amp;As<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.esma.europa.eu\/press-news\/esma-news\/new-qas-available-17\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\"><\/td>\n<\/tr>\n<tr class=\"row-73\">\n\t<td class=\"column-1\">07\/05\/2024<\/td><td class=\"column-2\">Approval process for white papers of ARTs issued by credit institutions<\/td><td class=\"column-3\">EBA<\/td><td class=\"column-4\">Issuers<\/td><td class=\"column-5\">RTS<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.eba.europa.eu\/sites\/default\/files\/2024-05\/1f78ca69-f9b1-4fe8-bd63-12754e76d3d5\/Final%20report%20on%20draft%20RTS%20white%20paper%20approval%20process%20under%20MiCAR.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">EBA\/RTS\/2024\/05<\/td>\n<\/tr>\n<tr class=\"row-74\">\n\t<td rowspan=\"6\" class=\"column-1\">07\/03\/2024<\/td><td class=\"column-2\">Public disclosure of inside information<\/td><td class=\"column-3\">ESMA<\/td><td class=\"column-4\">CASPs, Issuers, <br \/>\nOthers (Market abuse)<\/td><td class=\"column-5\">ITS<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a target=\"_blank\" href=\"https:\/\/www.esma.europa.eu\/sites\/default\/files\/2024-07\/ESMA75-453128700-1229_Final_Report_MiCA_CP2.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">ESMA75-453128700-1229<\/td>\n<\/tr>\n<tr class=\"row-75\">\n\t<td class=\"column-2\">Requirements for crypto-asset white papers<\/td><td class=\"column-3\">ESMA<\/td><td class=\"column-4\">Issuers<\/td><td class=\"column-5\">RTS, ITS<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a target=\"_blank\" href=\"https:\/\/www.esma.europa.eu\/sites\/default\/files\/2024-07\/ESMA75-453128700-1229_Final_Report_MiCA_CP2.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">ESMA75-453128700-1229<\/td>\n<\/tr>\n<tr class=\"row-76\">\n\t<td class=\"column-2\">Order book record-keeping for CASPs<\/td><td class=\"column-3\">ESMA<\/td><td class=\"column-4\">CASPs<\/td><td class=\"column-5\">RTS<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a target=\"_blank\" href=\"https:\/\/www.esma.europa.eu\/sites\/default\/files\/2024-07\/ESMA75-453128700-1229_Final_Report_MiCA_CP2.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">ESMA75-453128700-1229<\/td>\n<\/tr>\n<tr class=\"row-77\">\n\t<td class=\"column-2\">Trade transparency reporting for CASPs<\/td><td class=\"column-3\">ESMA<\/td><td class=\"column-4\">CASPs<\/td><td class=\"column-5\">RTS<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a target=\"_blank\" href=\"https:\/\/www.esma.europa.eu\/sites\/default\/files\/2024-07\/ESMA75-453128700-1229_Final_Report_MiCA_CP2.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">ESMA75-453128700-1229<\/td>\n<\/tr>\n<tr class=\"row-78\">\n\t<td class=\"column-2\">Business continuity obligations for CASPs<\/td><td class=\"column-3\">ESMA<\/td><td class=\"column-4\">CASPs<\/td><td class=\"column-5\">RTS<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a target=\"_blank\" href=\"https:\/\/www.esma.europa.eu\/sites\/default\/files\/2024-07\/ESMA75-453128700-1229_Final_Report_MiCA_CP2.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">ESMA75-453128700-1229<\/td>\n<\/tr>\n<tr class=\"row-79\">\n\t<td class=\"column-2\">Environmental sustainability metrics for distributed ledgers<\/td><td class=\"column-3\">ESMA<\/td><td class=\"column-4\">CASPs, Issuers<\/td><td class=\"column-5\">RTS<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a target=\"_blank\" href=\"https:\/\/www.esma.europa.eu\/sites\/default\/files\/2024-07\/ESMA75-453128700-1229_Final_Report_MiCA_CP2.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">ESMA75-453128700-1229<\/td>\n<\/tr>\n<tr class=\"row-80\">\n\t<td rowspan=\"6\" class=\"column-1\">06\/27\/2024<\/td><td class=\"column-2\">Suitability assessments of the management body and holders of qualifying holdings in issuers of ARTs and CASPs<\/td><td class=\"column-3\">ESMA, EBA<\/td><td class=\"column-4\">Issuers, CASPs<\/td><td class=\"column-5\">Guideline<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.eba.europa.eu\/sites\/default\/files\/2024-06\/2a0668ab-5d70-495a-a723-f6568fe8c830\/Joint%20GL%20suitability%20members%20management%20body%20and%20QH%20%28MiCAR%29.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">EBA\/GL\/2024\/09<br \/>\n <br \/>\nESMA75-453128700-10<br \/>\n<\/td>\n<\/tr>\n<tr class=\"row-81\">\n\t<td class=\"column-2\">Annex I : Reporting Templates<\/td><td class=\"column-3\">EBA<\/td><td class=\"column-4\">Issuers<\/td><td class=\"column-5\">Annex ITS<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.eba.europa.eu\/sites\/default\/files\/2024-06\/d721fe94-cc70-4896-ba9f-df4a4276e3af\/ANNEX I  Reporting for issuers of asset-referenced token  templates.xlsx\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">-<\/td>\n<\/tr>\n<tr class=\"row-82\">\n\t<td class=\"column-2\">Annex II : Reporting Instructions<\/td><td class=\"column-3\">EBA<\/td><td class=\"column-4\">Issuers<\/td><td class=\"column-5\">Annex ITS<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.eba.europa.eu\/sites\/default\/files\/2024-06\/84aed9a5-634c-413f-9b7c-6bc2053a672a\/ANNEX II  Reporting for issuers of asset-referenced token - instructions.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">-<\/td>\n<\/tr>\n<tr class=\"row-83\">\n\t<td class=\"column-2\">Annex III : Reporting for CASPs - Templates<\/td><td class=\"column-3\">EBA<\/td><td class=\"column-4\">CASPs<\/td><td class=\"column-5\">Annex ITS<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.eba.europa.eu\/sites\/default\/files\/2024-06\/0793ca04-6f8b-43fe-8f44-1fb7a976fb2a\/ANNEX III  Reporting for crypto-asset service providers  templates.xlsx\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">-<\/td>\n<\/tr>\n<tr class=\"row-84\">\n\t<td class=\"column-2\">Annex IV : Reporting for CASPs - Instructions<\/td><td class=\"column-3\">EBA<\/td><td class=\"column-4\">CASPs<\/td><td class=\"column-5\">Annex ITS<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.eba.europa.eu\/sites\/default\/files\/2024-06\/e1724776-9a8d-450d-946a-44ec0f64366c\/ANNEX IV  Reporting for crypto-asset service providers - instructions.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">-<\/td>\n<\/tr>\n<tr class=\"row-85\">\n\t<td class=\"column-2\">Annex V : Data Point Model and validation rules<\/td><td class=\"column-3\">EBA<\/td><td class=\"column-4\">ARTs and CASPs<\/td><td class=\"column-5\">Annex ITS<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.eba.europa.eu\/sites\/default\/files\/2024-06\/744b9126-7324-45c1-a25a-1eb1a1597ab7\/ANNEX V - DPM and validation rules.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">-<\/td>\n<\/tr>\n<tr class=\"row-86\">\n\t<td rowspan=\"3\" class=\"column-1\">06\/19\/2024<\/td><td class=\"column-2\">Supervisory colleges under MiCA<br \/>\n<\/td><td class=\"column-3\">EBA<\/td><td class=\"column-4\">CASPs, Issuers<\/td><td class=\"column-5\">RTS<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.eba.europa.eu\/sites\/default\/files\/2024-06\/a4ac65e2-fd2c-45a3-98d3-1f9aa5ac608b\/Final%20Report%20on%20RTS%20on%20colleges%20under%20MiCAR.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">EBA\/ RTS \/2024\/14<\/td>\n<\/tr>\n<tr class=\"row-87\">\n\t<td class=\"column-2\">The use of ARTs and EMTs denominated in a non-EU currency<\/td><td class=\"column-3\">EBA<\/td><td class=\"column-4\">Issuers<\/td><td class=\"column-5\">RTS<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.eba.europa.eu\/sites\/default\/files\/2024-06\/4befe99b-36d3-4b92-96b1-13a0f47e039a\/Final%20Report%20on%20RTS%20on%20use%20of%20ARTs%20and%20EMTs%20as%20a%20means%20of%20exchange%20under%20MICAR.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">EBA\/RTS\/2024\/13<\/td>\n<\/tr>\n<tr class=\"row-88\">\n\t<td class=\"column-2\">Reporting of ARTs and EMTs denominated in a non-EU currency<\/td><td class=\"column-3\">EBA<\/td><td class=\"column-4\">Issuers<\/td><td class=\"column-5\">ITS<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.eba.europa.eu\/sites\/default\/files\/2024-06\/a7bb4083-f886-4a44-8b03-3810155248a7\/Final%20Report%20on%20draft%20ITS%20on%20reporting%20on%20asset-referenced%20tokens%20under%20MiCAR.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">EBA\/ITS\/2024\/04<\/td>\n<\/tr>\n<tr class=\"row-89\">\n\t<td rowspan=\"6\" class=\"column-1\">06\/13\/2024<\/td><td class=\"column-2\">Guidelines on Recovery plans <\/td><td class=\"column-3\">EBA<\/td><td class=\"column-4\">CASPs, Issuers<\/td><td class=\"column-5\">Guideline<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.eba.europa.eu\/sites\/default\/files\/2024-06\/a4619671-df54-42ff-a6d8-2819f51ebe83\/Final%20report%20on%20Guidelines%20on%20recovery%20plans%20under%20MiCAR.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">EBA\/GL\/2024\/07<\/td>\n<\/tr>\n<tr class=\"row-90\">\n\t<td class=\"column-2\">Issuers stress testing and funds requirements<\/td><td class=\"column-3\">EBA<\/td><td class=\"column-4\">Issuers<\/td><td class=\"column-5\">Guideline<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.eba.europa.eu\/sites\/default\/files\/2024-06\/517f476a-186f-45b7-9a5c-7a5fc9cab5dd\/Final%20Report%20draft%20RTS%20on%20additional%20own%20funds%20requirements%20and%20stress%20testing%20Art%2035%206%20MiCAR.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">EBA\/RTS\/2024\/08<\/td>\n<\/tr>\n<tr class=\"row-91\">\n\t<td class=\"column-2\">Procedure and timeframe for funds requirements of significant ARTs and EMTs<\/td><td class=\"column-3\">EBA<\/td><td class=\"column-4\">Issuers<\/td><td class=\"column-5\">RTS<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.eba.europa.eu\/sites\/default\/files\/2024-06\/3786a572-7066-46f7-967b-cd3e3b45287c\/Final%20Report%20draft%20RTS%20on%20the%20procedure%20and%20timeframe%20to%20adjust%20own%20funds%20Art%2045%207%20c%20MiCAR.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">EBA\/RTS\/2024\/09<\/td>\n<\/tr>\n<tr class=\"row-92\">\n\t<td class=\"column-2\">Details on highly liquid financial products<\/td><td class=\"column-3\">EBA<\/td><td class=\"column-4\">Issuers<\/td><td class=\"column-5\">RTS<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.eba.europa.eu\/sites\/default\/files\/2024-06\/d92b94f8-8260-43b6-abae-d21e022414ed\/Final%20report_draft%20RTS%20to%20specify%20the%20HLFI%20in%20the%20reserve%20of%20assets%20Article%2038%205.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">EBA\/RTS\/2024\/11<\/td>\n<\/tr>\n<tr class=\"row-93\">\n\t<td class=\"column-2\">Further specifications on liquidity requirements of the reserve of assets<\/td><td class=\"column-3\">EBA<\/td><td class=\"column-4\">Issuers<\/td><td class=\"column-5\">RTS<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.eba.europa.eu\/sites\/default\/files\/2024-06\/580db2f3-8370-4927-baa3-0f995722b417\/Final%20report_draft%20RTS%20further%20specifying%20the%20liquidity%20requirements%20Article%2036%204.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">EBA\/RTS\/2024\/10<\/td>\n<\/tr>\n<tr class=\"row-94\">\n\t<td class=\"column-2\">Specifications on the minimum contents of the liquidity management policy and procedure of Issuers<\/td><td class=\"column-3\">EBA<\/td><td class=\"column-4\">Issuers<\/td><td class=\"column-5\">RTS<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.eba.europa.eu\/sites\/default\/files\/2024-06\/3f3557fa-deb0-4765-add9-51666791e12c\/Final%20report_draft%20RTS%20to%20specify%20the%20minimum%20content%20of%20liquidity%20management%20policy%20Article%2045%207.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">EBA\/RTS\/2024\/12<\/td>\n<\/tr>\n<tr class=\"row-95\">\n\t<td class=\"column-1\">06\/06\/2024<\/td><td class=\"column-2\">Policies and procedures regarding conflict of interest<\/td><td class=\"column-3\">EBA<\/td><td class=\"column-4\">Issuers<\/td><td class=\"column-5\">RTS<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.eba.europa.eu\/sites\/default\/files\/2024-06\/8c8b0d34-5f61-49d6-88c3-01ea6b0c0649\/Final%20report%20on%20draft%20RTS%20on%20conflicts%20of%20interest%20under%20MICAR.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">EBA\/RTS\/2024\/07<\/td>\n<\/tr>\n<tr class=\"row-96\">\n\t<td class=\"column-1\">06\/06\/2024<\/td><td class=\"column-2\">Minimum content of governance arrangements for issuers of ARTs<\/td><td class=\"column-3\">EBA<\/td><td class=\"column-4\">ARTs<\/td><td class=\"column-5\">Guideline<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.eba.europa.eu\/sites\/default\/files\/2024-06\/611ef3d4-4d67-467f-bf0d-4c2b1dd0ef5e\/Final%20report%20on%20draft%20Guidelines%20on%20internal%20governance%20of%20issuers%20of%20ARTs.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">EBA\/GL\/2024\/06<\/td>\n<\/tr>\n<tr class=\"row-97\">\n\t<td class=\"column-1\">06\/06\/2024<\/td><td class=\"column-2\">Minimum content of the governance arrangements on the remuneration policy for issuers of ARTs<\/td><td class=\"column-3\">EBA<\/td><td class=\"column-4\">Issuers<\/td><td class=\"column-5\">RTS<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"http:\/\/www.eba.europa.eu\/sites\/default\/files\/2024-06\/4998fc26-cc88-4ada-835c-292f831a4ccd\/Final%20report%20on%20draft%20RTS%20on%20governance%20arrangements%20for%20remuneration%20under%20%20MICAR.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">EBA\/RTS\/2024\/06<\/td>\n<\/tr>\n<tr class=\"row-98\">\n\t<td class=\"column-1\">05\/31\/2024<\/td><td class=\"column-2\">Conflicts of interest involving CASPs<\/td><td class=\"column-3\">ESMA<\/td><td class=\"column-4\">CASPs<\/td><td class=\"column-5\">RTS<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a target=\"_blank\" href=\"https:\/\/www.esma.europa.eu\/sites\/default\/files\/2024-05\/ESMA35-1872330276-1670_MiCA_Final_report_on_RTS_on_CoIs.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">ESMA18-72330276-1634<\/td>\n<\/tr>\n<tr class=\"row-99\">\n\t<td rowspan=\"4\" class=\"column-1\">03\/25\/2024<\/td><td class=\"column-2\">Complaint handling procedures for CASPs<\/td><td class=\"column-3\">ESMA<\/td><td class=\"column-4\">CASPs<\/td><td class=\"column-5\">RTS<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a target=\"_blank\" href=\"https:\/\/www.esma.europa.eu\/sites\/default\/files\/2024-03\/ESMA18-72330276-1634_Final_Report_on_certain_technical_standards_under_MiCA_First_Package.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">ESMA18-72330276-1634<\/td>\n<\/tr>\n<tr class=\"row-100\">\n\t<td class=\"column-2\">Conditions for acquiring CASPs<\/td><td class=\"column-3\">ESMA<\/td><td class=\"column-4\">CASPs<\/td><td class=\"column-5\">RTS<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a target=\"_blank\" href=\"https:\/\/www.esma.europa.eu\/sites\/default\/files\/2024-03\/ESMA18-72330276-1634_Final_Report_on_certain_technical_standards_under_MiCA_First_Package.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">ESMA18-72330276-1634<\/td>\n<\/tr>\n<tr class=\"row-101\">\n\t<td class=\"column-2\">Authorisation application process for CASPs<\/td><td class=\"column-3\">ESMA<\/td><td class=\"column-4\">CASPs<\/td><td class=\"column-5\">RTS, ITS<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a target=\"_blank\" href=\"https:\/\/www.esma.europa.eu\/sites\/default\/files\/2024-03\/ESMA18-72330276-1634_Final_Report_on_certain_technical_standards_under_MiCA_First_Package.pdf\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">ESMA18-72330276-1634<\/td>\n<\/tr>\n<tr class=\"row-102\">\n\t<td class=\"column-2\">Notification procedure for regulated financial institutions intending to offer crypto-asset services<\/td><td class=\"column-3\">ESMA<\/td><td class=\"column-4\">Issuers<\/td><td class=\"column-5\">RTS, ITS<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.google.ca\/?hl=fr\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">ESMA18-72330276-1634<\/td>\n<\/tr>\n<tr class=\"row-103\">\n\t<td class=\"column-1\">03\/13\/2024<\/td><td class=\"column-2\">Complaint handling procedures for ARTs\u2019 issuers<\/td><td class=\"column-3\">EBA<\/td><td class=\"column-4\">Issuers<\/td><td class=\"column-5\">RTS<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.eba.europa.eu\/sites\/default\/files\/2024-03\/22e7f584-a1d9-44eb-8b07-ab0bdbb3b4d2\/Draft%20RTS%20on%20complaints%20handling%20under%20MiCAR.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">EBA\/RTS\/2024\/02<\/td>\n<\/tr>\n<tr class=\"row-104\">\n\t<td rowspan=\"3\" class=\"column-1\">07\/12\/2023<\/td><td class=\"column-2\">Conditions for the acquisition of ARTs\u2019 issuers<\/td><td class=\"column-3\">EBA<\/td><td class=\"column-4\">Issuers<\/td><td class=\"column-5\">RTS<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.eba.europa.eu\/sites\/default\/files\/document_library\/Publications\/Consultations\/2023\/Consultation%20on%20information%20for%20assessment%20of%20a%20proposed%20acquisition%20of%20qualifying%20holdings%20in%20issuers%20of%20ARTs%20under%20MiCAR\/1057530\/CP%20RTS%20information%20for%20notification%20QH%20under%20MiCAR.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">EBA\/CP\/2023\/14<\/td>\n<\/tr>\n<tr class=\"row-105\">\n\t<td class=\"column-2\">Details for the authorisation of ART issuers<\/td><td class=\"column-3\">EBA<\/td><td class=\"column-4\">Issuers<\/td><td class=\"column-5\">RTS, ITS<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.eba.europa.eu\/sites\/default\/files\/document_library\/Publications\/Consultations\/2023\/Consultation%20paper%20on%20draft%20Technical%20Standards%20on%20information%20for%20authorisation\/1057529\/MiCAR%20CP%20RTS-ITS%20information%20for%20authorisation.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">EBA\/CP\/2023\/15<\/td>\n<\/tr>\n<tr class=\"row-106\">\n\t<td class=\"column-2\">EU market access for ARTs' issuers<\/td><td class=\"column-3\">EBA<\/td><td class=\"column-4\">Issuers<\/td><td class=\"column-5\">RTS, ITS<\/td><td class=\"column-6\">-<\/td><td class=\"column-7\"><a href=\"https:\/\/www.eba.europa.eu\/sites\/default\/files\/document_library\/Publications\/Consultations\/2023\/Consultation%20paper%20on%20draft%20Technical%20Standards%20on%20information%20for%20authorisation\/1057529\/MiCAR%20CP%20RTS-ITS%20information%20for%20authorisation.pdf\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dnapartners.fr\/wp-content\/uploads\/2024\/11\/icon-link.png\" alt=\"\" width=\"31\" height=\"31\" class=\"alignnone size-full wp-image-1974\" \/><\/a><\/td><td class=\"column-8\">EBA\/CP\/2023\/15<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<!-- #tablepress-1 from cache -->\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":12,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"pages\/page-mica.php","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-1993","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.1.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>MiCA Tracker \u2013 Crypto &amp; MiCA Regulation Updates | D&amp;A Partners<\/title>\n<meta name=\"description\" content=\"Discover our MiCA Tracker, which provides an overview of the delegated acts, technical standards, and guidelines related to MiCA.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/dnapartners.fr\/en\/mica-standards-and-guidelines-tracker\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MiCA Tracker \u2013 Crypto &amp; MiCA Regulation Updates | D&amp;A Partners\" \/>\n<meta property=\"og:description\" content=\"Discover our MiCA Tracker, which provides an overview of the delegated acts, technical standards, and guidelines related to MiCA.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/dnapartners.fr\/en\/mica-standards-and-guidelines-tracker\/\" \/>\n<meta property=\"og:site_name\" content=\"d&amp;a partners\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-27T14:33:31+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/dnapartners.fr\/en\/mica-standards-and-guidelines-tracker\/\",\"url\":\"https:\/\/dnapartners.fr\/en\/mica-standards-and-guidelines-tracker\/\",\"name\":\"MiCA Tracker \u2013 Crypto & MiCA Regulation Updates | D&A Partners\",\"isPartOf\":{\"@id\":\"https:\/\/dnapartners.fr\/#website\"},\"datePublished\":\"2024-11-28T10:04:41+00:00\",\"dateModified\":\"2025-01-27T14:33:31+00:00\",\"description\":\"Discover our MiCA Tracker, which provides an overview of the delegated acts, technical standards, and guidelines related to MiCA.\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/dnapartners.fr\/en\/mica-standards-and-guidelines-tracker\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/dnapartners.fr\/#website\",\"url\":\"https:\/\/dnapartners.fr\/\",\"name\":\"d&amp;a partners\",\"description\":\"Avocats des entrepreneurs de la Tech et la Blockchain\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/dnapartners.fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MiCA Tracker \u2013 Crypto & MiCA Regulation Updates | D&A Partners","description":"Discover our MiCA Tracker, which provides an overview of the delegated acts, technical standards, and guidelines related to MiCA.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/dnapartners.fr\/en\/mica-standards-and-guidelines-tracker\/","og_locale":"en_US","og_type":"article","og_title":"MiCA Tracker \u2013 Crypto & MiCA Regulation Updates | D&A Partners","og_description":"Discover our MiCA Tracker, which provides an overview of the delegated acts, technical standards, and guidelines related to MiCA.","og_url":"https:\/\/dnapartners.fr\/en\/mica-standards-and-guidelines-tracker\/","og_site_name":"d&amp;a partners","article_modified_time":"2025-01-27T14:33:31+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/dnapartners.fr\/en\/mica-standards-and-guidelines-tracker\/","url":"https:\/\/dnapartners.fr\/en\/mica-standards-and-guidelines-tracker\/","name":"MiCA Tracker \u2013 Crypto & MiCA Regulation Updates | D&A Partners","isPartOf":{"@id":"https:\/\/dnapartners.fr\/#website"},"datePublished":"2024-11-28T10:04:41+00:00","dateModified":"2025-01-27T14:33:31+00:00","description":"Discover our MiCA Tracker, which provides an overview of the delegated acts, technical standards, and guidelines related to MiCA.","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/dnapartners.fr\/en\/mica-standards-and-guidelines-tracker\/"]}]},{"@type":"WebSite","@id":"https:\/\/dnapartners.fr\/#website","url":"https:\/\/dnapartners.fr\/","name":"d&amp;a partners","description":"Avocats des entrepreneurs de la Tech et la Blockchain","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dnapartners.fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/dnapartners.fr\/en\/wp-json\/wp\/v2\/pages\/1993","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dnapartners.fr\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/dnapartners.fr\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/dnapartners.fr\/en\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/dnapartners.fr\/en\/wp-json\/wp\/v2\/comments?post=1993"}],"version-history":[{"count":2,"href":"https:\/\/dnapartners.fr\/en\/wp-json\/wp\/v2\/pages\/1993\/revisions"}],"predecessor-version":[{"id":2004,"href":"https:\/\/dnapartners.fr\/en\/wp-json\/wp\/v2\/pages\/1993\/revisions\/2004"}],"wp:attachment":[{"href":"https:\/\/dnapartners.fr\/en\/wp-json\/wp\/v2\/media?parent=1993"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}